Indications for use Hypoxen are:

Reduced performance when working in extreme situations and difficult to adapt climatic conditions (the Far North, highlands, etc.), chronic fatigue syndrome, severe injuries and surgical interventions, blood loss, extensive burns, chronic obstructive pulmonary disease, bronchial asthma, lung abscesses , septic pneumonia (as part of complex therapy).

Pharmachologic effect:

Antihypoxic, antioxidant. Prevents the development of free radical oxidation reactions and the formation of lipid peroxides, stimulates the destruction of peroxidation products. Differs in high electron volumetric capacity due to polymerization of phenolic nuclei in the ortho position. The antihypoxic effect is associated with the presence of a polyphenolic quinone component in the structure, which is involved in the respiratory chain of electron transfer (shunts their transport). In mitochondria, it maintains a high level of tissue respiration and aerobic processes, leveling the negative consequences of hypoxia. In the post-hypoxic period, it promotes the rapid oxidation of the accumulated reduced equivalents - nicotinamide adenine dinucleotide phosphate (NADP, NADPH2), optimizes the work of mitochondria and increases the efficiency of tissue respiration. Increases tolerance to physical and mental stress. The use as a part of complex endolymphatic therapy (olifen in combination with an antibiotic and an antiviral drug) in patients with destructive pneumonia and septic conditions reduces endotoxicosis, shortens the recovery time, normalizes the interferon status and local immunological parameters.